Bronchial diseases
Conditions
Interventions
Sufentanil group:Intravenous injection of sufentanil
Osalidine group:Intravenous injection of oxaliplatin
Sponsors
Enze Hospital, Taizhou Enze Medical Center (Group)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Age range of 18 to 80 years old; 2.ASA Level I-II; 3.BMI<30kg/m^2;
Exclusion criteria
Exclusion criteria: 1.Surgical time>30 minutes; 2.History of allergies to propofol, soybeans, or eggs; 3.Individuals with neurological and psychiatric disorders and those taking related medications; 4.Individuals with damage to target organs such as liver, kidney, heart, and brain; 5.Patients with language communication barriers who are unable to cooperate; 6.Past memory or cognitive impairment, sleep apnea syndrome, and difficult airway.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient and doctor satisfaction ratings;Record MAP, HR, and SpO2 at six different time points; | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of Propofol Injection Pain;Total dosage of propofol;Anesthesia recovery status from the end of surgery to the patient's departure;Occurrence of nausea and vomiting within 24 hours after the examination;Occurrence of adverse events: intraoperative body movement, sinus bradycardia, hypotension;The patient's general condition, including sex, weight, age, height, and duration of examination; | — |
Countries
China
Contacts
Public ContactXiang Haifei
Enze Hospital, Taizhou Enze Medical Center (Group)
Outcome results
None listed